Mohan Pankaj 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Dec 5, 2024
Insider Transaction Report
Form 4
Mohan Pankaj
DirectorChairman, President and CEO
Transactions
- Award
Common Stock
2023-12-11+7,554→ 14,987 total
Holdings
- 3(indirect: By Children)
Common Stock
- 377(indirect: By Mohan Family Office)
Common Stock
Footnotes (4)
- [F1]On December 11, 2023, the Reporting Person was granted 7,554 restricted stock awards, which will be settled in shares of common stock, par value $0.0001. The shares in connection with the restricted stock award become fully vested on January 1, 2025.
- [F2]Includes unvested restricted stock awards.
- [F3]All amounts reflect the Issuer's 1:22 reverse stock split effective as of September 30, 2024.
- [F4]Reporting Person jointly exercises dispositive and voting power over the securities owned by the Mohan Family Office.